Chronic Spontaneous Urticaria (CSU) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
Chronic Spontaneous Urticaria (CSU) Market Outlook Thelansis’s “Chronic Spontaneous Urticaria (CSU) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Spontaneous Urticaria (CSU) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Chronic Spontaneous Urticaria (CSU) Overview Chronic spontaneous urticaria (CSU), also called chronic idiopathic urticaria, is characterized by the occurrence of urticaria for 6 weeks or longer without identifiable specific triggers. The average duration of CSU is frequently reported as 5 years, but it may be longer in more severe cases, specifically in patients with concurrent angioedema. P...